Worth reading
66In focus
Scored from 3 of 5 sectionsDirection
Neutral
Direction inferred from the company’s description.Scale
1550000
SharesWording
Definitive
How definitive the wording is.Details of issuance or disposal
Exercise status report for the 11th stock acquisition rights issued through a third-party allotment (with an exercise price adjustment clause)
Who receives how much
Shares delivered during the relevant month: 1,550,000 new shares and 0 treasury shares transferred
EVO FUND (issued on 26 December 2025)
The lower thin line represents the existing number of shares to which these shares will be added.
発行済株式総数
Exercise ratio for the relevant month: 2.2% (against the total issue of 700,000 rights)
The dilution rate shows what proportion the newly issued shares represent of the existing shares. The higher the proportion, the more the value and voting rights per share are diluted.
Terms of the stock acquisition rights
Exercise price
¥31 on 1 June 2026 and ¥30 from 2 to 4 June. Details of the adjustment clause: Not disclosed
Number of Stock Acquisition Rights
Total issued: 700,000 rights; unexercised as of the end of the month preceding the relevant month: 570,500 rights; unexercised as of the end of the relevant month: 555,000 rights
Procedures under the Corporate Code of Conduct
Statement of compliance with the exercise restrictions under Article 434 of the Tokyo Stock Exchange's Securities Listing Regulations and the Japan Securities Dealers Association's Rules Concerning the Handling of Third-Party Allotments, etc.
Most recent equity financing
26 December 2025: Issuance of the 11th Stock Acquisition Rights, with EVO FUND as the allottee (detailed amount: Not disclosed)
| Item | Details |
|---|---|
| Type of issuance or disposal | Exercise status report for the 11th stock acquisition rights issued through a third-party allotment (with an exercise price adjustment clause) |
| Number of shares to be issued or disposed of | Shares delivered during the relevant month: 1,550,000 new shares and 0 treasury shares transferred |
| Intended allottee | EVO FUND (issued on 26 December 2025) |
| Dilution Rate | Exercise ratio for the relevant month: 2.2% (against the total issue of 700,000 rights) |
| Total number of issued shares | 88,305,233 shares (as of the end of the month preceding the relevant month, including 9,227 treasury shares) → Not disclosed |
| Exercise price | ¥31 on 1 June 2026 and ¥30 from 2 to 4 June. Details of the adjustment clause: Not disclosed |
| Number of Stock Acquisition Rights | Total issued: 700,000 rights; unexercised as of the end of the month preceding the relevant month: 570,500 rights; unexercised as of the end of the relevant month: 555,000 rights |
| Procedures under the Corporate Code of Conduct | Statement of compliance with the exercise restrictions under Article 434 of the Tokyo Stock Exchange's Securities Listing Regulations and the Japan Securities Dealers Association's Rules Concerning the Handling of Third-Party Allotments, etc. |
| Most recent equity financing | 26 December 2025: Issuance of the 11th Stock Acquisition Rights, with EVO FUND as the allottee (detailed amount: Not disclosed) |
Items this document does not state (19)
Issue price and disposal priceTotal issue valueAmount of funds to be raisedEstimated issuance expensesSpecific use of fundsPayment dateIntended allottee's holding policyBasis for determining the amount to be paidExercise periodTransfer restriction periodConditions for lifting transfer restrictionsReason for acquisition without considerationCategories and Number of Persons CoveredTotal Stock-Based CompensationUnderwriter / lead underwriterOverallotmentStock Split RatioMajor shareholders after the offeringImpact on Business Performance
These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.
The reasons the company gives
The company's own explanation, not something inferred from the numbers.To report the monthly exercise status for June 2026.
How to read this page
This is not the documentKomori reads the disclosure the company filed and writes this summary. Figures are as stated by the company and are not audited.
Weight is not a verdictIt measures how much this changes what the company had already told the market. It is not a view on the shares.
Corrections happenIf the company reissues this disclosure, the page is rebuilt from the corrected version and the revision number moves up.